Colchicine After Electrocardioversion for Atrial Fibrillation
Conditions
Atrial Fibrillation · Cardiac Arrhythmia
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Cantonal Hospital Baselland (KSBL), Bruderholz, Basel-Landschaft, Switzerland
Contact: Study coordinator (Christian Maurer, Dr. med.) · christian.maurer@ksbl.ch, · +41 61 436 21 90Contact: Principal Investigator (Christian Maurer, Dr. med.)University Hospital Basel, Basel, Switzerland
Contact: Study coordinator (Christian Sticherling, Prof.) · christian.sticherling@usb.ch · +41 61 265 55 26Contact: Principal Investigator (Christian Sticherling, Prof.)Philipp Krisai, PD Dr. med. (Sub-investigator)University Hospital Bern, Bern, Switzerland
Contact: Principal Investigator (Tobias Reichlin, Prof.)Lausanne University Hospital, Lausanne, Switzerland
Contact: Principal Investigator (Etienne Pruvot, Prof. Dr.)Lucerne Cantonal Hospital, Lucerne, Switzerland
Contact: Principal Investigator (Ann-Kathrin Gamer, MD)Cantonal Hospital Olten, Olten, Switzerland
Contact: Study coordinator (Frank-Peter Stephan, MD) · frank-peter.stephan@spital.so.ch · +41 32 627 35 52Contact: Principal Investigator (Frank-Peter Stephan, MD)Herzpraxis am Rhein, Rheinfelden, Switzerland
Contact: Principal Investigator (Flavio Scarcia, MD)Solothurner Spitäler AG, Solothurn, Switzerland
Contact: Study coordinator (Frank-Peter Stephan, MD) · frank-peter.stephan@spital.so.ch · +41 32 627 35 52Contact: Principal Investigator (Frank-Peter Stephan)
Study leads
Philipp Krisai, PD Dr. med.
Principal Investigator
University Hospital, Basel, Switzerland